跳至主要内容
临床试验/CTRI/2017/12/010965
CTRI/2017/12/010965已完成未知

ong term outcome and side effect profiles of treating adult onset minimal change disease with tacrolimus versus steroid as the first line agent

IPGMER and SSKM Hospital kolkata0 个研究点目标入组 48 人开始时间: 待定最近更新:

试验速览

阶段
未知
状态
已完成
发起方
入组人数
48

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • All patients aged over 18 years with biopsy-proven MCD with an Immunofluorescence staining negative for all stains and presence of nephrotic range proteinuria ( >3.5gms/24hours) will be taken for study.

排除标准

  • The patients with any other glomerular or tubulo-interstitial pathology in the biopsy (including any overlap syndrome or variants of MCD), chronicity features on histopathology (interstitial fibrosis and tubular atrophy >20%), presence of active infection and prior exposure to any immunosuppressive agents for the same disease were excluded from the study. Patients with systemic diseases like SLE, diagnosed lymphoma/leukemia or suspicion of drug induced MCD were excluded.

研究者

发起方
IPGMER and SSKM Hospital kolkata

相似试验